CTAG2 and urinary bladder carcinoma: Furthermore, Memorial Sloan-Kettering Cancer Center and The National Cancer Institute have completed a phase I vaccine trial of NY-ESO-1, BCG, and sargramostim in patients who recently underwent cystectomy for bladder cancer and express NY-ESO-1 and/or LAGE-1 antigens histologically.